{"status":"OK","data":{"advertisement":{"id":244564,"title":"ZAPYTANIE OFERTOWE nr 1/2024/G/STEP7","partial_offer_allowed":false,"publication_date":"2024-03-06","submission_deadline":"2024-03-13 23:59:59","planned_sign_date":"2024-03-01","supplementary_orders":null,"terms_of_contract_change":null,"created_at":"2024-03-06 13:52:04","modified_at":"2024-03-14 00:00:03","contact_persons":[{"id":64,"forename":"Paulina","surname":"Gruszka","phone_number":"","email":"paulina.gruszka@celonpharma.com","created_by":null,"created_at":"2025-05-14 12:08:24","modified_at":"2025-05-14 12:08:24","modified_by":null}],"orders":[{"id":396996,"estimated_value":null,"order_items":[{"id":447733,"description":"Przeprowadzenie badania maksymalnej tolerowanej dawki u ps\u00f3w z zastosowaniem doustnej drogi podania.\n\nDodatkowe informacje:\n\uf02d\tZamawiaj\u0105cy deklaruje gotowo\u015b\u0107 rozpocz\u0119cia realizacji programu badawczego okre\u015blonego w niniejszym dokumencie do 18.03.2024,\n\uf02d\tRaport wst\u0119pny zostanie wystawiony do 31.05.2024,\n\uf02d\tPlanowany program bada\u0144 b\u0119dzie prowadzony w standardzie non-GLP,\n\uf02d\tPlanowany program bada\u0144 b\u0119dzie prowadzony zgodnie z wytycznymi naukowymi Europejskiej Agencji Lek\u00f3w dotycz\u0105cymi nieklinicznego badania lek\u00f3w,\n\uf02d\tJ\u0119zyk angielski musi by\u0107 u\u017cywany we wszystkich celach zwi\u0105zanych z przygotowywaniem dokument\u00f3w i sprawozdawczo\u015bci\u0105.","warranty_period":null,"cpv_items":[{"id":8513,"code":"73100000-3","name":"Us\u0142ugi badawcze i eksperymentalno-rozwojowe"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"\u0142\u00f3dzkie","poviat":"\u0141\u00f3d\u017a","commune":"\u0141\u00f3d\u017a-\u015ar\u00f3dmie\u015bcie","locality":"\u0141\u00f3d\u017a","created_by":null,"created_at":"2024-03-06 13:52:04","modified_at":"2024-03-06 13:52:04","modified_by":null,"id":501731,"type":{"id":1,"name":"adres"},"group_uuid":"9491ae85-d8a6-43fa-9efd-331d37ae8223"}],"participation_conditions":[{"id":1226030,"description":"\u201eO\u015bwiadczenie o braku powi\u0105za\u0144 personalnych i kapita\u0142owych z Zamawiaj\u0105cym\u201d","type":{"id":6,"name":"Lista wymaganych dokument\u00f3w/o\u015bwiadcze\u0144"},"created_by":null,"created_at":"2024-03-06 13:52:04","modified_at":"2024-03-06 13:52:04","modified_by":null,"group_uuid":"32a2ba7c-4bf6-4282-a445-2e7cfd2a169e"},{"id":1226031,"description":"Oferent zobligowany jest do podpisania klauzuli poufno\u015bci z Zamawiaj\u0105cym w celu uzyskania szczeg\u00f3\u0142owych informacji umo\u017cliwiaj\u0105cych mu konstrukcj\u0119 oferty","type":{"id":7,"name":"Dodatkowe warunki udzia\u0142u"},"created_by":null,"created_at":"2024-03-06 13:52:04","modified_at":"2024-03-06 13:52:04","modified_by":null,"group_uuid":"549c1535-0092-4cc0-ae80-8255ed325c3c"}],"category":{"id":1,"name":"Us\u0142uga"},"subcategory":{"id":4,"name":"Us\u0142ugi badawcze"},"created_by":null,"created_at":"2024-03-06 13:52:04","modified_at":"2024-03-06 13:52:04","modified_by":null,"group_uuid":"6233651f-6c5c-4c17-892f-fed5613da918"}],"evaluation_criteria":[{"id":682268,"price_criterion":true,"description":"Cena (P) \u2013 100 pkt (100%)","created_by":null,"created_at":"2024-03-06 13:52:04","modified_at":"2024-03-06 13:52:04","modified_by":null,"group_uuid":"d4ee04af-1848-4926-9428-11e3004fba32"}],"is_variant":false,"title":"Przeprowadzenie badania","order_node":{"id":298328},"created_by":null,"created_at":"2024-03-06 13:52:04","modified_at":"2024-03-06 13:52:04","modified_by":null}],"created_by":{"id":177,"contact_persons":[]},"modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":2,"label":"PUBLISHED","name":"Opublikowane"},"advertiser_address_details":{"name":"Celon Pharma S.A.","identification_number_type":"nip","identification_number":"1181642061","address":{"country":"Polska","voivodeship":"mazowieckie","poviat":"warszawski zachodni","commune":"\u0141omianki","locality":"Kie\u0142pin","created_by":{"id":177,"contact_persons":[]},"created_at":"2024-03-06 13:52:04","modified_at":"2024-03-06 13:52:04","modified_by":{"id":177,"contact_persons":[]},"id":652080,"street":"Ogrodowa ","number_description":"2A","postcode":"05-092"},"created_by":{"id":177,"contact_persons":[]},"created_at":"2024-03-06 13:52:04","modified_at":"2024-03-06 13:52:04","modified_by":{"id":177,"contact_persons":[]},"id":245121},"advertisement":{"id":184491,"number":"2024-177-184491","publication_date":"2024-02-05","created_by":{"id":177,"contact_persons":[]},"created_at":"2024-02-05 13:47:06","modified_at":"2024-03-14 00:00:03","modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":6,"label":"RESOLVED","name":"Rozstrzygni\u0119te"},"all_available_version_ids":[242462,244564],"enrollment":null,"projects":[{"id":43570,"name":"Serotoninergiczna terapia przeciwb\u00f3lowa oparta o agonist\u0119 receptora 5-HT7 (STEP7) - II faza","number":"1017/23","activity":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:22:25","modified_at":"2023-02-01 09:22:25","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"region":null,"institution":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:27:55","modified_at":"2023-02-01 09:27:55","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"full_number":"FENG.01.01-IP.01-1017/23","perspective":{},"programme":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:21:41","modified_at":"2023-02-01 09:21:41","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"priority":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:21:51","modified_at":"2023-02-01 09:21:51","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"type":"project","created_by":{"id":177,"contact_persons":[]},"created_at":"2024-01-17 11:09:27","modified_at":"2024-01-17 11:09:27","modified_by":{"id":177,"contact_persons":[]}}],"is_author":false,"is_admin":false},"attachments":[{"origin":{"id":242462,"publication_date":"2024-02-05"},"id":1239110,"name":"Zapytanie ofertowe","file":{"id":1381161,"name":"ZO_1_2024_G_STEP7.pdf","created_at":"2024-03-06 13:52:04","created_by":{"forename":"Paulina","surname":"Gruszka"},"uri":"/api/files/1381161"},"group_uuid":"2ebde284-56ac-4977-88fc-2de43fcac050"},{"origin":{"id":242462,"publication_date":"2024-02-05"},"id":1239111,"name":"O\u015bwiadczenie","file":{"id":1381163,"name":"zal. 1 Oswiadczenie o braku powiazan FENG.docx","created_at":"2024-03-06 13:52:04","created_by":{"forename":"Paulina","surname":"Gruszka"},"uri":"/api/files/1381163"},"group_uuid":"bff83501-9c8d-4921-9665-83cda769409e"},{"origin":{"id":242462,"publication_date":"2024-02-05"},"id":1239112,"name":"RfQ","file":{"id":1381164,"name":"RfQ_1_2024_G_STEP7.pdf","created_at":"2024-03-06 13:52:04","created_by":{"forename":"Paulina","surname":"Gruszka"},"uri":"/api/files/1381164"},"group_uuid":"cfe7b3ac-d983-4afb-9261-1fc686f37b73"},{"origin":{"id":242462,"publication_date":"2024-02-05"},"id":1239113,"name":"Att. 1 Statement","file":{"id":1381165,"name":"att. 1 Statement.docx","created_at":"2024-03-06 13:52:04","created_by":{"forename":"Paulina","surname":"Gruszka"},"uri":"/api/files/1381165"},"group_uuid":"57a53212-fa11-4087-a5ab-a35d4248af91"}]},"dictionaries":{"announcement_status_draft":1,"announcement_status_published":2},"favorite":null,"badge":null,"offer_set_badge_count":null,"question_badge_count":null}}